Stock listing
Clene Inc.
Selected listing: CLNN · NASDAQ · USD · US
Clene Inc. (NASDAQ:CLNN), Health Technology. Latest release Sep 22, 2026: Clene to Present at Upcoming Investor Conferences.
- Ticker
- NASDAQ:CLNN
- Asset type
- Stock
- Sector
- Health Technology
- Industry
- Pharmaceuticals: Major
- Exchange
- NASDAQ
- Currency
- USD
About Clene Inc.
The company focuses on developing innovative therapies for neurodegenerative diseases. Clene aims to improve patient outcomes through its unique approach to treatment.
Latest news from Clene Inc.
Clene to Present at Upcoming Investor Conferences
September 22, 2026
Clene Announces Closing of $4 Million Registered Direct Offering Extending Capital Runway Beyond FDA Decision on CNM-Au8® NDA
September 21, 2026
Clene Announces $4 Million Registered Direct Offering
September 15, 2026
Clene to Present at Upcoming September Investor Conferences
September 3, 2026
Clene Reports Second Quarter 2026 Financial Results and Recent Operating Highlights
August 14, 2026
Research Clene Inc.
Alternate listings
CLNN:BOATS
US · USD
Alternate listing for Clene Inc.; the primary context on this page is CLNN:NASDAQ.
84C0:FWB
DE · EUR
Alternate listing for Clene Inc.; the primary context on this page is CLNN:NASDAQ.
84C0:TRADEGATE
DE · EUR
Alternate listing for Clene Inc.; the primary context on this page is CLNN:NASDAQ.